University Advancement

  • Oviatt Library

Vir Biotechnology, Inc. Announces Executive Appointments

Previously, from March 2021 to February 2023, he was at Capsida Biotherapeutics, Inc., most recently as Head of Finance. Prior to that, Mr. Sabatini was at Amgen Inc. from April 2004 to March 2021 where he progressed through various positions of increasing responsibility, including leadership roles in Accounting, Tax and Financial Planning and Analysis. Mr. Sabatini is a Certified Public Accountant and received a B.S. in Accountancy from California State University, Northridge and an MBA from the University of Michigan?s Stephen M. Ross School of Business.

https://www.marketscreener.com/quote/stock/VIR-BIOTECHNOLOGY-INC-66771988/news/Vir-Biotechnology-Inc-Announces-Executive-Appointments-47840264/

--Market Screener

Clip Category

Alumni